Due to the limited heating efficiency of available magnetic nanoparticles, it is difficult to achieve therapeutic temperatures above 44 °C in relatively inaccessible tumors during magnetic hyperthermia following systemic administration of nanoparticles at clinical dosage (≤10 mg kg−1). To address this, a method for the preparation of magnetic nanoparticles with ultrahigh heating capacity in the presence of an alternating magnetic field (AMF) is presented. The low nitrogen flow rate of 10 mL min−1 during the thermal decomposition reaction results in cobalt‐doped nanoparticles with a magnetite (Fe3O4) core and a maghemite (γ‐Fe2O3) shell that exhibit the highest intrinsic loss power reported to date of 47.5 nH m2 kg−1. The heating efficiency of these nanoparticles correlates positively with increasing shell thickness, which can be controlled by the flow rate of nitrogen. Intravenous injection of nanoparticles at a low dose of 4 mg kg−1 elevates intratumoral temperatures to 50 °C in mice‐bearing subcutaneous and metastatic cancer grafts during exposure to AMF. This approach can also be applied to the synthesis of other metal‐doped nanoparticles with core–shell structures. Consequently, this method can potentially be used for the development of novel nanoparticles with high heating performance, further advancing systemic magnetic hyperthermia for cancer treatment.
Recently, therapeutics based on mRNA (mRNA) have attracted
significant
interest for vaccines, cancer immunotherapy, and gene editing. However,
the lack of biocompatible vehicles capable of delivering mRNA to the
target tissue and efficiently expressing the encoded proteins impedes
the development of mRNA-based therapies for a variety of diseases.
Herein, we report mRNA-loaded polymeric nanoparticles based on diethylenetriamine-substituted
poly(aspartic acid) that induce protein expression in the lungs and
muscles following intravenous and intramuscular injections, respectively.
Animal studies revealed that the amount of polyethylene glycol (PEG)
on the nanoparticle surface affects the translation of the delivered
mRNA into the encoded protein in the target tissue. After systemic
administration, only mRNA-loaded nanoparticles modified with PEG at
a molar ratio of 1:1 (PEG/polymer) induce protein expression in the
lungs. In contrast, protein expression was detected only following
intramuscular injection of mRNA-loaded nanoparticles with a PEG/polymer
ratio of 10:1. These findings suggest that the PEG density on the
surface of poly(aspartic acid)-based nanoparticles should be optimized
for different delivery routes depending on the purpose of the mRNA
treatment.
Photoacoustic imaging (PAI) has tremendous potential for improving ovarian cancer detection. However, the lack of effective exogenous contrast agents that can improve PAI diagnosis accuracy significantly limits this application. This study presents a novel contrast nanoagent with a specific spectral signature that can be easily distinguished from endogenous chromophores in cancer tissue, allowing for high‐contrast tumor visualization. Constructed as a 40 nm biocompatible polymeric nanoparticle loaded with two naphthalocyanine dyes, this agent is capable of efficient ovarian tumor accumulation after intravenous injection. The developed nanoagent displays a spectral signature with two well‐separated photoacoustic peaks of comparable PA intensities in the near‐infrared (NIR) region at 770 and 860 nm, which remain unaffected in cancer tissue following systemic delivery. In vivo experiments in mice with subcutaneous and intraperitoneal ovarian cancer xenografts validate that this specific spectral signature allows for accurate spectral unmixing of the nanoagent signal from endogenous contrast in cancer tissue, allowing for sensitive noninvasive cancer diagnosis. In addition, this nanoagent can selectively eradicate ovarian cancer tissue with a single dose of photothermal therapy by elevating the intratumoral temperature to ≈49 °C upon exposure to NIR light within the 700–900 nm range.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.